Li Weilin, Wang Caidang, Zhang Junli
Taizhou Municipal Hospital of Traditional Chinese Medicine, Zhejiang Province 318000.
J Tradit Chin Med. 2003 Dec;23(4):251-4.
To study the clinical effects of Da Ding Feng Zhu ([symbol: see text]) Decoction on liver fibrosis. 56 patients with liver fibrosis due to chronic hepatitis B were randomly divided into a treatment group (30 cases treated with Da Ding Feng Zhu Decoction) and a control group (26 cases treated with colchicine). The serum levels of hyaluronic acid (HA), procollagen III (PC-III), IV collagen (IV-C) and Laminin (LN) of the patients were determined, compared and analyzed before treatment and after 3-month treatment in the two groups. The results showed that in the treatment group, the levels of HA, PC-III, IV-C and LN after 3-month treatment were significantly lowered as compared to that before treatment (P < 0.01). In the control group, only the HA level was obviously lowered (P < 0.05). There was an significant difference (P < 0.05) in PC-III and IV-C and a very significant difference (P < 0.01) in HA after treatment between the two groups. It is therefore concluded that Da Ding Feng Zhu Decoction can lower serum indexes of liver fibrosis.
观察大定风珠汤治疗肝纤维化的临床疗效。将56例慢性乙型肝炎肝纤维化患者随机分为治疗组(30例,给予大定风珠汤治疗)和对照组(26例,给予秋水仙碱治疗)。分别于治疗前及治疗3个月后测定并比较分析两组患者血清透明质酸(HA)、Ⅲ型前胶原(PC-Ⅲ)、Ⅳ型胶原(Ⅳ-C)及层粘连蛋白(LN)水平。结果显示,治疗组治疗3个月后HA、PC-Ⅲ、Ⅳ-C及LN水平较治疗前显著降低(P<0.01);对照组仅HA水平明显降低(P<0.05)。两组治疗后PC-Ⅲ、Ⅳ-C水平比较,差异有统计学意义(P<0.05),HA水平比较,差异有非常显著统计学意义(P<0.01)。结论:大定风珠汤可降低肝纤维化血清指标。